Brainchip share price rockets 30% higher on NASA program collaboration

The Brainchip Holdings Ltd (ASX:BRN) share price is rocketing higher after announcing a collaboration with VORAGO for a NASA program…

| More on:
Rocket launching into space

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Brainchip Holdings Ltd (ASX: BRN) share price has been on fire again on Wednesday morning.

At the time of writing the artificial intelligence technology company's shares are up 30% to a 52-week high of 40.5 cents.

Why is the Brainchip share price rocketing higher?

Investors have been scrambling to buy Brainchip's shares this morning after it announced a collaboration with VORAGO Technologies.

VORAGO Technologies is a privately held, high technology company based in Texas with over 15 years of experience in providing radiation-hardened and extreme-temperature solutions for the Hi-reliability marketplace.

According to the release, it is recognised as one of Inc 5000's Fastest Growing Private Companies in America.

VORAGO's patented HARDSIL technology uses cost-effective high-volume manufacturing to harden any commercially designed semiconductor component for extreme environment operation. It has created a number of solutions throughout Aerospace, Defense, and Industrial applications.

What is the collaboration?

Management advised that the collaboration is intended to support a Phase I NASA program for a neuromorphic processor that meets spaceflight requirements.

The agreement includes payments that are intended to offset the its expenses to support partner needs.

BrainChip's CEO, Louis DiNardo, commented: "We are both excited and proud to participate in this Phase I program with VORAGO Technologies and support NASA's desire to leverage neuromorphic computing in spaceflight applications. The combination of benefits from the Akida neuromorphic processor and a radiation-hardened process brings significant new capabilities to spaceflight and aerospace applications."

The company notes that its Akida neuromorphic processor is uniquely suited for spaceflight and aerospace applications. The device is a complete neural processor and does not require an external CPU, memory or Deep Learning Accelerator.

This is important as reducing component count, size, and power consumption are paramount concerns in spaceflight and aerospace applications.

Bernd Lienhard, VORAGO CEO, commented: "We are thrilled and honored to partner with BrainChip to harness the radiation hardening capabilities of our patented HARDSIL technology for the Phase I program with NASA. Our ongoing mission of creating components with increased availability and unmatched solutions in aerospace and defense applications paired with the Akida neuromorphic processor will create unprecedented standards moving forward in the industry."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »